Billionaire investor Chamath Palihapitiya files for 4 new biotech-focused SPACs that seek to raise $800 million

Chamath Palihapitiya filed for four blank-check companies on Wednesday along with a new partner, according to paperwork registered with the Securities and Exchange Commission.

The latest additions build on his roster of 6 special-purpose acquisition companies already raised, yielding more than $1 billion. 

The four new SPACs are launched under a partnership between Palihapitiya’s venture firm Social Capital and hedge fund Suvretta Capital Management. One of Suvretta’s core investing strategies is to identify companies that are disruptive to the healthcare sector .

The companies may initially pursue a combination target in any industry as part of its proposed business strategy, filings state.

Click Here To Read More…

Annually.com is Available for Purchase. Learn more by clicking the button here:

Get Pricing Info